FindTrial
Sign In

Comparison of drug prucalopride with polyethylene glycol and polyethylene glycol alone for colonoscopy

A Randomized,case controlled open label study to evaluate safety and efficacy of prucalopride with PEG versus PEG alone for colonoscopy preparation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037369
Enrollment
100
Registered
2021-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K638- Other specified diseases of intestine

Interventions

Intervention1: Prucalopride with PEG: Prucalopride, a dihydrobenzofuran carboxamide derivative is the first selective 5HT4 agonist with gastrointestinal (GIT) prokinetic properties and minimal interac

Sponsors

Dr RPGMC kangra at Tanda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients in age group 18-75 years coming for colonoscopy

Exclusion criteria

Exclusion criteria: 1. Uncooperative patients/Non Consenting 2. Known or suspected colonic perforation 3. Severe toxic megacolon and fulminant colitis 4. Clinically unstable patients 5. Recent myocardial infarction 6. Renal dysfunction 7. Known Hypersensitivity to study drugs 8. Pregnant Females

Design outcomes

Primary

MeasureTime frame
Better colon preparationTimepoint: During & after procedure—

Secondary

MeasureTime frame
Safety in terms of least adverse effectsTimepoint: During & after procedure—

Countries

India

Contacts

Public ContactDr Dinesh Kansal

Dr RPGMC kangra at Tanda

satwindersinghchauhan@gmail.com9815708740

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026